Loading
VI
Veradigm Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by STONEHILL CAPITAL MANAGEMENT LLC, was filed 04 Mar 2024.
Veradigm Inc.: what insiders have been doing
This page follows insider dealings at Veradigm Inc. as filed with SEC (Form 4), a company from the Health Care sector. From 20 October 2025 to 20 October 2026, the disclosure feed for Veradigm Inc. logged 7 filings by 5 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Across the 5,453 companies tracked on its exchange, the median is 22 filings; at 7 filings, this issuer sits below that mark. Over the whole record (from 2016), the tally stands at 9 purchases and 70 sales.
Over the last twelve months, not one insider purchase of Veradigm Inc. stock was filed. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
339
Thresholds
n/a
Buy Volume
€18M
9 ops. · all time
Sell Volume
€28M
70 ops. · all time
Since the insiders bought
- -21.3%Entry US$6.80 · Close at T+365 US$5.35
- +98.4%Entry US$7.64 · Close at T+365 US$15.16
- +98.4%Entry US$7.64 · Close at T+365 US$15.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Veradigm Inc. Strong Buy (bullish), based on 1 analysts. Average price target: US$8.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,996 of 26,279 companies
39.4
score / 100
Value48
Quality31
FCF yld16%
Earn yld-17%
EV/EBITDA12.6x
ROE-31%
Gross mgn52%
Net mgn-15%
Debt/EBITDA3.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2022FY ended December 2022 · cache
US$4.74
Analyst consensus
1 analystsStrong buy
US$8.00Target US$8.00(+69%)US$8.00
Income statement
RevenueUS$588M
Gross profitUS$308.4M52% margin
EBITDAUS$58.4M10% margin
Net income-US$86.5M-49.0% margin
Valuation
P/Book0.6x
Beta0.51
Balance sheet & cash
Market capUS$516.6M
Total debtUS$219.4M
Free Cash FlowUS$83.3M
Debt / Equity19%
Profitability & ownership
ROE-31.0%
ROA-3.7%
% insiders4.4%
% institutions62.0%
Last declaration on 3 June 2026
Declarations339 total
42,507 shares0Common StockSEC:0001193125-26-255566:0
42,507 shares0Common Stock, par value $0.01 per shareSEC:0001012975-26-000520:0
220,986 shares0Common StockSEC:0001193125-26-142132:0
552,465 shares0Common StockSEC:0001193125-26-142094:0
110,493 shares0Common StockSEC:0001193125-26-142118:0
423,998 shares0Common StockSEC:0001193125-25-267291:0
105,999 shares0Common StockSEC:0001193125-25-267296:0
571,428 shares@ US$5.25100.0% of flowCommon StockSEC:0000950170-25-112886:0
58,140 shares@ US$4.3071.5% of flowCommon StockSEC:0000950170-25-082540:0
69,768 shares@ US$4.3049.1% of flowCommon StockSEC:0000950170-25-082532:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081244:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081243:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081245:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081241:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081240:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081239:0
8,696 sharesCommon Stock, par value $0.01 per shareSEC:0001062993-25-010909:0
8,696 sharesCommon Stock, par value $0.01 per shareSEC:0001062993-25-010908:0
1,526 shares@ US$4.401.9% of flowCommon StockSEC:0000950170-25-077680:0
3,169 shares@ US$4.302.3% of flowCommon StockSEC:0000950170-25-069514:0
2,087 shares@ US$4.302.6% of flowCommon StockSEC:0000950170-25-069515:0
1,893 shares@ US$4.403.8% of flowCommon StockSEC:0000950170-25-063537:0
2,481 shares@ US$4.255.1% of flowCommon StockSEC:0000950170-25-050539:0
227 shares@ US$4.250.3% of flowCommon StockSEC:0000950170-25-049512:0
10,112 shares0Common StockSEC:0000950170-25-045626:0
25 of 339 declarations
About Veradigm Inc.
Veradigm Inc. is a company specializing in technology solutions for the healthcare sector. It offers tools to enhance care efficiency and manage medical data.
